Tetra Bio-Pharma Targets Multi-Billion Dollar Fibromyalgia Market
Tetra Bio-Pharma Inc. today announced a co-development agreement with Storz & Bickel to use a specialized medical device known as the Mighty Medic, in combination with its PPP001 prescription drug as well as with additional indications and a future proprietary cannabinoid formulation.